Autoimmune and Inflammatory Immunomodulators 2016 Global Market Expected to Grow at CAGR 7.01% and Forecast to 2020

Pune India - November 18, 2016 /MarketersMEDIA/ —

The analysts forecast the global autoimmune and inflammatory immunomodulators market to grow at a CAGR of 7.01% during the period 2016-2020.

Immunomodulators are the drugs that help to regulate the immune system. These drugs either stimulate the weak immune systems or moderate the overactive immune systems. Though many drugs are available in the market, there still exists a huge unmet need in the autoimmune and inflammatory immunomodulators market as there are no medicines that provide complete cure to some diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn’s disease.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/742762-global-autoimmune-and-inflammatory-immunomodulators-market-2016-2020

For more information or any query mail at sales@wiseguyreports.com

Covered in this report

The report covers the present scenario and the growth prospects of the global autoimmune and inflammatory immunomodulators market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

The report, Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• AbbVie
• Johnson & Johnson
• Amgen
• F. Hoffmann-La Roche
• Pfizer

Complete Report Details @ https://www.wiseguyreports.com/reports/742762-global-autoimmune-and-inflammatory-immunomodulators-market-2016-2020

Other prominent vendors
• AstraZeneca
• Avaxia Biologics
• Biogen Idec
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Eli Lilly
• Enlivex Therapeutics
• Gilead Sciences
• Immune Pharmaceuticals
• Merck
• Mitsubishi Tanabe Pharma
• Neovacs
• Prometheus Laboratories
• Sandoz
• Sanofi
• Swedish Orphan Biovitrum
• Takeda Pharmaceuticals
• UCB

Market driver
• Development of novel therapies using innovative technologies.
• For a full, detailed list, view our report

Market challenge
• Discontinuation of drugs under development leading to substantial loss in revenue.
• For a full, detailed list, view our report

Market trend
• Advent of biosimilars expected to improve the treatment rates.
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table Of Contents – Major Key Points

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Autoimmune and inflammatory diseases
• Rheumatoid arthritis
• IBD
• Top immunomodulators for rheumatoid arthritis and IBD

PART 06: Pipeline portfolio

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by type of disease
• Global rheumatoid arthritis immunomodulators market
• Global IBD immunomodulators market

PART 09: Market segmentation by molecule type
• Global autoimmune and inflammatory biologic immunomodulators market
• Global autoimmune and inflammatory small molecule immunomodulators market

PART 10: Geographical segmentation
• Global autoimmune and inflammatory immunomodulators market by geography 2015-2020
• Autoimmune and inflammatory immunomodulators market in Americas
• Autoimmune and inflammatory immunomodulators market in EMEA
• Autoimmune and inflammatory immunomodulators market in APAC

PART 11: Market drivers
• Strong adoption of TNF-alpha inhibitors and B-cell inhibitors
• Development of novel therapies using innovative technologies
• Improved diagnostic tools increase the treatment-seeking population

PART 12: Impact of drivers

PART 13: Market challenges
• Discontinuation of drugs under development leading to substantial loss of revenue
• Growing popularity of alternative treatment procedures hinders the market growth
• Adverse effects of the drugs

..……CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=742762

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028
Phone: +1-646-845-9349
Website: https://www.wiseguyreports.com

Release ID: 145865